| Description |
Set to more than quadruple from $48 to $208bn over the next 15 years, the global regenerative medicine market is set for stellar growth as therapies begin entering the clinic.
Regenerative medicine is set to revolutionize healthcare as stem cell, tissue engineering, gene therapy and materials science come together to transform patient treatment. Bringing you the latest in translational applications from leading experts, don’t miss this exceptional showcase of medical innovations in this fast-moving field.
By attending this conference you will gain the latest insights into:
• The economic future of the global regenerative medicine market and acquiring venture capital
• The use of stem cell therapies in type 1 diabetes
• Small molecule drugs to stimulate neurogenesis and neuroprotection in Parkinson’s disease
• The use of direct stem cell therapies in cardiovascular diseases
• The use of direct stem cell therapies in wound healing
• The use of direct stem cell therapies in bone remodelling
• Gene therapy for retinal degeneration
• Scaling-up in the lab
• Scaling up in manufacturing
• Clinical trials for novel therapies
• How to commercialise your product
• Overcoming patent, legal and regulatory hurdles
Who will be there?
Presidents, Chief Executive Officers, VPs, Chief Scientific Officers, Directors, Business Development Managers, and Principal Scientists of:
• Adult Stem Cell Research
• Embryonic Stem Cell Research
• Tissue Engineering
• Translational Medicine
• Gene Therapy
• Bioengineering and Bioprocessing
• Biotechnology
• Cell Therapy
• Biomaterials
• Neuroscience
• Diabetes
• Cardiovascular Medicine
• Pharmacology
• Pharmacogenomics
• Proteomics
• Personalised Medicine
• Business Development
• Strategic Alliances
• New Product Development
• Pharmacovigilance
• Process Development
• Manufacturing
• Clinical Trials
• Licensing and External Research
|
|
